Streetbeat News

Marketing

CNVS

Cineverse (NASDAQ:CNVS) launched Cineverse 360, an omnichannel ad platform reaching over 82 million monthly viewers across 1.2 billion devices. It integrates CTV, FAST, audio, digital, social, and events, targeting enthusiast audiences in genres like anime, family, and horror. Terry City joins as SVP and Head of Cineverse 360. The platform also introduces the Cineverse 360 Audience Network for scalable advertising solutions, including partnerships with third-party publishers and platforms like Philo and Samsung TV Plus. Matchpoint's Blueprint product integrates with Cineverse 360, offering monetization services. Andrew Baritz is brought on to oversee ad operations and strategy. A case study on Bloody Disgusting highlights the platform's success in engaging horror fans, showing an 11% ad revenue increase in 2023.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 5:03 pm

BZFD

The Independent is in talks to take control of BuzzFeed and HuffPost's operations in the UK and Ireland, aiming to expand in a challenging advertising climate. The deal includes editorial and commercial control, staff transfers, and a strategic partnership for content and tech support. This move comes as digital advertising faces hurdles due to Google's decision to end third-party tracking cookies, impacting revenue generation. The partnership aims to leverage combined audiences for better commercial offerings and reflects the industry's shift towards first-party data for advertising.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 4:31 pm

LLY

NVO

Eli Lilly's obesity drug Mounjaro, also approved for diabetes, launches in the UK, making it the first major market for its prefilled pen version. The UK, with Europe's highest obesity rate, sees Superdrug and Simple Online Pharmacy offering the drug to both NHS and private patients. The launch follows MHRA's approval and marks a significant step for Eli Lilly, competing with Novo Nordisk's Wegovy. Pricing for a 4-week course starts at £189 for private patients.

Portfolio Pulse from Vandana Singh

February 15, 2024 | 3:09 pm

INOD

Wolfpack Research has issued a report on Innodata Inc. (NASDAQ:INOD), criticizing its AI claims as 'smoke and mirrors' and highlighting its reliance on manual data-entry and offshore labor. The report details INOD's low R&D spend, financial struggles, and insider stock sales, suggesting the company's stock will revert to its historical levels due to its inability to pivot to AI. It contrasts INOD's performance and investment in AI with that of its competitors and major tech companies, concluding that INOD's AI claims are misleading.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:52 pm

VMAR

Vision Marine Technologies Inc. (NASDAQ:VMAR) unveiled the Phantom, a rotomolded boat, at the Miami International Boat Show 2024, highlighting its economic and environmental benefits. The Phantom, designed for efficiency and affordability, can produce up to 300 units annually at a cost 70% lower than fiberglass alternatives. Vision Marine secured an exclusive distribution deal with Nautical Ventures Marine Group for Florida, including an initial order of 50 units. The Phantom is recyclable, seats up to 10 passengers, and supports both electric and gas motors, making it appealing for a variety of activities.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:19 pm

PUBM

SATS

PubMatic (NASDAQ:PUBM) has partnered with DISH Media (NASDAQ:SATS) to enhance programmatic advertising demand for SLING TV. This partnership allows SLING TV to leverage PubMatic's supply path optimization and access premium demand through private marketplace deals. The collaboration aims to capitalize on the growing trend of ad-supported streaming, with vMVPD viewership expected to increase significantly. DISH Media will provide valuable content signals for better targeting and campaign ROI. The partnership also offers advertisers access to premium SLING TV content, including live sports and major global events, which are anticipated to drive ad spending in 2024.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:09 pm

IVDA

Iveda (NASDAQ:IVDA) has expanded its smart city technology footprint in Egypt by opening a new office in Cairo and a strategic demonstration showcase within the Arab Organization for Industrialization (AOI) government facility. This move, following a partnership with AOI six months ago, aims to display Iveda's 5G, AI, and sustainable technology innovations, including the Utilus Smart Pole. The collaboration supports Egypt's plan to introduce 38 new smart cities by 2050, leveraging Iveda's IoT and AI expertise. Egypt's AI market is expected to grow significantly, reaching $601.8 million by 2030. Major General Ashraf Hassan, a recent addition to Iveda's Advisory Board, will play a key role in promoting Iveda's technologies in the region.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:06 pm

AMLX

Amylyx Pharmaceuticals will present updates on its AMX0114 and RELYVRIO programs for ALS at the 2024 Muscular Dystrophy Association Clinical and Scientific Conference. This indicates progress in their ALS treatment research.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:04 pm

SNES

SenesTech has entered into an exclusive distribution agreement with Q-chem to distribute its Evolve Soft Bait product in the Netherlands. This partnership aims to expand the reach of SenesTech's innovative rodent control solution in the European market.

Portfolio Pulse from Benzinga Newsdesk

February 15, 2024 | 2:02 pm

BTCUSD

CSCO

ETHUSD

LMT

PFE

Cryptocurrencies surge with Bitcoin's market cap surpassing $1 trillion, potentially hitting $60K. US markets see mixed movements, with Cisco issuing a weak outlook. Global politics and economy updates include sanctions on Russia and BRICS nations challenging G7 dominance. Tech highlights include Uber's price target boost and Apple's AI chip advancements. Electric Vehicle sector notes Tesla's market strategies and challenges. New York City sues major social platforms over mental health concerns. Pfizer settles a lawsuit, and Lockheed Martin faces budget cuts on F-35 orders.

Portfolio Pulse from Akanksha Bakshi

February 15, 2024 | 2:02 pm